| BioID | bio1997 |
| Name | FARGLITAZAR |
| ChEMBL ID | CHEMBL107367 |
| Molecular Formula | C34H30N2O5 |
| Molecular Weight | 546.62 |
| Molecular Weight (Monoisotopic) | 546.2155 |
| Type | Small molecule |
| Max Phase | Phase 2 |
| Target ID | Tar12 |
| Target Name | Toll-like receptor 9 (TLR9) |
| Synonyms | FARGLITAZAR|G1-262570|GI-262570|GI-262570X|GI262570|GI262570X|farglitazar |
| Smiles | Cc1oc(-c2ccccc2)nc1CCOc1ccc(C[C@H](Nc2ccccc2C(=O)c2ccccc2)C(=O)O)cc1 |
| Inchi | InChI=1S/C34H30N2O5/c1-23-29(36-33(41-23)26-12-6-3-7-13-26)20-21-40-27-18-16-24(17-19-27)22-31(34(38)39)35-30-15-9-8-14-28(30)32(37)25-10-4-2-5-11-25/h2-19,31,35H,20-22H2,1H3,(H,38,39)/t31-/m0/s1 |
| Inchi Key | ZZCHHVUQYRMYLW-HKBQPEDESA-N |
| Molecular Species | ACID |
| Targets | 12.0 |
| Bioactivities | 78.0 |
| Np Likeness Score | -0.81 |
| Records Key | ['20', 'FARGLITAZAR', 'Farglitazar', 'GI 262570', 'FARGLITAZAR', '2', '5', '12', 'GI 262570', 'SID144210538', 'Farglitazar', '20(S)', 'farg', '2', '2393', 'Farglitazar'] |
| Records Name | ['(S)-2-(2-Benzoyl-phenylamino)-3-{4-[2-(5-methyl-2-phenyl-oxazol-4-yl)-ethoxy]-phenyl}-propionic acid', 'FARGLITAZAR', '(S)-2-(2-Benzoyl-phenylamino)-3-{4-[2-(5-methyl-2-phenyl-oxazol-4-yl)-ethoxy]-phenyl}-propionic acid', '2-(2-Benzoyl-phenylamino)-3-{4-[2-(5-methyl-2-phenyl-oxazol-4-yl)-ethoxy]-phenyl}-propionic acid (GI 262570)', 'FARGLITAZAR', '(S)-2-(2-Benzoyl-phenylamino)-3-{4-[2-(5-methyl-2-phenyl-oxazol-4-yl)-ethoxy]-phenyl}-propionic acid', 'farglitazar', '(S)-2-(2-benzoylphenylamino)-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic acid', '(S)-2-(2-benzoylphenylamino)-3-(4-(2-(5-methyl-2-phenyloxazol-4-yl)ethoxy)phenyl)propanoic acid', 'SID144210538', 'Farglitazar', 'Farglitazar', 'Farglitazar', '2-(2-Benzoyl-phenylamino)-3-{4-[2-(5-methyl-2-phenyl-oxazol-4-yl)-ethoxy]-phenyl}-propionic acid', None, 'Farglitazar'] |
| Withdrawn Flag | False |
| Orphan | 0 |